Inhibition of adrenal dopamine-beta-hydroxylase by 6-hydroxy dopamine.
D000313:Adrenal Medulla / Q000201:enzymology*; D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism / Q000494:pharmacology; D002374:Catalase / Q000378:metabolism / Q000494:pharmacology; D002417:Cattle; D002838:Chromaffin System / Q000201:enzymology / Q000378:metabolism; D003864:Depression, Chemical; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004347:Drug Interactions; D006861:Hydrogen Peroxide / Q000378:metabolism; D006892:Hydroxydopamines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D008970:Molecular Weight; D010084:Oxidation-Reduction; D010293:Pargyline / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D012710:Serum Albumin, Bovine / Q000494:pharmacology; D013997:Time Factors; D014439:Tyramine / Q000378:metabolism
D006892:Hydroxydopamines; D011506:Proteins; D012710:Serum Albumin, Bovine; D010293:Pargyline; D006861:Hydrogen Peroxide; D007490:Iproniazid; D002374:Catalase; D004299:Dopamine beta-Hydroxylase; D001205:Ascorbic Acid; D014439:Tyramine